Journal article

Publication year: 2022

Pages: 245-24+

Journal: Deutsches Ärzteblatt International

Volume number: 119

Issue number: 14

ISSN: 1866-0452

Open access status: Green

DOI Link: https://doi.org/10.3238/arztebl.m2022.0094

Publisher: Deutscher Ärzte-Verlag

Abstract: 

Background: Many people with diabetes have permanently elevated blood sugar concentrations and a high level of diabetes-related psychological stress. also called "diabetes distress." In clinical practice, diabetes distress is often an impediment to successful self-management. psy-PAD is a psychodynamically oriented short-term therapy program whose goal is to reduce diabetes distress and improve glycemic control.

Methods: A randomized controlled trial was conducted with 143 patients with either type 1 or type 2 diabetes who were being treated in eleven specialized diabetological practices. psy-PAD in the intervention group (eight sessions) was compared with optimized standard care as the control condition. The inclusion criteria were HbA1c >= 7.5% combined with diabetes distress (PAID >35, or doctor's determination). The primary endpoint was the HbA1c at six months (t(1)). Diabetes-related distress (PAID), depressive symptoms (HADS-D, PHQ-9), anxiety symptoms (HADS-A), health-related quality of life (SF-36), panic (short form of the PHQ-D), body mass index (BMI), and triglyceride levels were secondary endpoints. Follow-ups were conducted at six (t(1)) and 12 months (t(2)) (trial registration: DRKS00003247).

Results: The intergroup comparison at t 1 revealed a significant, clinically relevant reduction of HbA1c by -0.53 percentage points (95% confidence interval [-0.89; -0.16], p = 0.005). The secondary analyses revealed relevant differences in the point estimators for diabetes distress at t(1) and t(2), depressive symptoms at t(2) and BMI at t(1).

Conclusion: For people with diabetes and diabetes distress who do not achieve satisfactory glycemic control despite intensive treatment in specialized diabetological practices. integrated psychosomatic-psychotherapeutic treatment can lower blood sugar levels over the intermediate term and also reduce diabetes distress and depressive symptoms over a one-year period.

Harvard Citation style: Kampling, H., Koehler, B., Germerott, I., Haastert, B., Icks, A., Kulzer, B., et al. (2022) An Integrated Psychosomatic Treatment Program for People with Diabetes (psy-PAD), Deutsches Ärzteblatt International, 119(14), pp. 245-24+. https://doi.org/10.3238/arztebl.m2022.0094

APA Citation style: Kampling, H., Koehler, B., Germerott, I., Haastert, B., Icks, A., Kulzer, B., Nowotny, B., Hermanns, N., & Kruse, J. (2022). An Integrated Psychosomatic Treatment Program for People with Diabetes (psy-PAD). Deutsches Ärzteblatt International. 119(14), 245-24+. https://doi.org/10.3238/arztebl.m2022.0094